Ollberry Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-07-2024
- Paid Up Capital ₹ 0.11 M
as on 05-07-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
as on 05-07-2024
- Revenue 174.45%
(FY 2021)
- Profit 605.96%
(FY 2021)
- Ebitda 327.44%
(FY 2021)
- Net Worth 119.62%
(FY 2021)
- Total Assets 102.92%
(FY 2021)
About Ollberry Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.11 M.
The company currently has active open charges totaling ₹1.00 M.
Sushanta Paul and Rumi Sarma serve as directors at the Company.
- CIN/LLPIN
U36999AS2019PTC019031
- Company No.
019031
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Feb 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ollberry Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushanta Paul  | Director | 04-Mar-2022 | Current |
| Rumi Sarma | Director | 19-Feb-2019 | Current |
Financial Performance of Ollberry Lifesciences.
Ollberry Lifesciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 174.45% increase. The company also saw a substantial improvement in profitability, with a 605.96% increase in profit. The company's net worth Soared by an impressive increase of 119.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ollberry Lifesciences?
In 2021, Ollberry Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Dec 2023 | ₹1.00 M | Open |
How Many Employees Work at Ollberry Lifesciences?
Ollberry Lifesciences has a workforce of 6 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ollberry Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ollberry Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
